
-
SFWJ / Medcana Announces Strategic Expansion Into Australia With Acquisition of Cannabis Import and Distribution Licenses
-
Arsenal's Havertz could return for Champions League final
-
US officials split on Ukraine truce prospects
-
Client brain-dead after Paris cryotherapy session goes wrong
-
Flick demands answers from La Liga for 'joke' schedule
-
'Maddest game' sums up Man Utd career for Maguire
-
Trial opens for students, journalists over Istanbul protests
-
Gaza rescuers say Israeli strikes kill 24 after Hamas rejects truce proposal
-
'Really stuck': Ukraine's EU accession drive stumbles
-
'Not the time to discuss future', says Alonso amid Real Madrid links
-
74 killed in deadliest US attack on Yemen, Huthis say
-
Southgate's ex-assistant Holland fired by Japan's Yokohama
-
Vance meets Meloni in Rome before Easter at the Vatican
-
Ryan Gosling to star in new 'Star Wars' film
-
Hamas calls for pressure to end Israel's aid block on Gaza
-
Russia says Ukraine energy truce over, US mulls peace talks exit
-
58 killed in deadliest US strike on Yemen, Huthis say
-
Museums rethink how the Holocaust should be shown
-
Three dead after deadly spring storm wreaks havoc in the Alps
-
No need for big changes at Liverpool, says Slot
-
Bloody Philippine passion play sees final performance of veteran 'Jesus'
-
New US envoy prays, delivers Trump 'peace' message at Western Wall
-
Postecoglou sticking around 'a little longer' as Spurs show fight in Frankfurt
-
US threatens to withdraw from Ukraine talks if no progress
-
Tears and defiance in Sumy as Russia batters Ukraine border city
-
Russia rains missiles on Ukraine as US mulls ending truce efforts
-
Tokyo leads gains in most Asian markets on trade deal hopes
-
Two missing after deadly spring snowstorm wreaks havoc in the Alps
-
'War has taken everything': AFP reporter returns home to Khartoum
-
US strikes on Yemen fuel port kill 38, Huthis say
-
Slegers targets Lyon scalp in pursuit of Arsenal European glory
-
'Defend ourselves': Refugee girls in Kenya find strength in taekwondo
-
China's manufacturing backbone feels Trump trade war pinch
-
Sri Lankans throng to Kandy for rare display of Buddhist relic
-
Chinese vent anger at Trump's trade war with memes, mockery
-
Heartbroken Brits abandon pets as living costs bite
-
Mongolian LGBTQ youth fight for recognition through music, comedy
-
Cash crunch leaves Syrians queueing for hours to collect salaries
-
Lyon left to regroup for Champions League bid after painful European exit
-
Unravelling Real Madrid face Athletic Bilbao Liga test
-
Napoli disturbing buoyant Inter's peace in Serie A Easter bonanza
-
Disappointed Dortmund chase consistency with Europe at stake
-
Asian markets mixed as traders track tariff talks
-
Yan and Buhai share lead at LA Championship
-
Under fire at debate, Canada PM Carney tries to focus on Trump
-
Liverpool poised for Premier League coronation, Leicester, Ipswich for relegation
-
India's elephant warning system tackles deadly conflict
-
US senator meets wrongfully deported Salvadoran migrant
-
Gustavo Dudamel: the superstar conductor building bridges to pop
-
Japan rice prices soar as core inflation accelerates

Fantribe (TM) Inc. Announces Proposed "Go Public" Transaction With Tritent International Corp.
-Popular Social Media Platform For Athletes and Celebrities To Be Acquired by Tritent International Corp. in RTO Transaction
-Popular Social Media Platform For Athletes and Celebrities To Be Acquired by Tritent International Corp. in RTO Transaction
Fantribe™ Inc. (http://fantribe.com), a Florida based technology and media Company is pleased to announce that the Company has entered into an agreement and Memorandum of Understanding on December 15, 2024 to be acquired through a tax-free share exchange and definitive agreement by Tritent International Corp. , a public Company on the OTC Markets Exchange. The two companies are expected to complete the Definitive Share Exchange Agreement within the next thirty (30) days. The completion of the transaction is contingent upon various terms and conditions, including the successful completion of due diligence, the execution of a definitive agreement by January 15, 2025 and approval from both companies' shareholders and OTC Markets. The acquisition of Fantribe Inc. will be for one-hundred (100) percent of the outstanding shares in Fantribe Inc. in an all-share, tax-free share exchange transaction.
Fantribe™ http://fantribe.com/ is a revolutionary digital platform connecting athletes, celebrities, and influencers directly with their fans. Our mission is to provide a unique, engaging, and monetizable experience for all parties involved. Fantribe enables athletes and celebrities to create and sell exclusive content, such as behind-the-scenes footage, training sessions, and personalized messages.
"We are extremely excited to be involved in this "go public" transaction for Fantribe™ with our new partners at Tritent. Our ability to access public and capital markets through being a publically traded Company will enable our Fantribe platform and partners to take advantage institutional funding and international audience to put us on an immediate growth trajectory for our athletes, celebrities and fans subscribing to the platform as well as create meaningful shareholder value in the weeks ahead", stated Michael Friedman, President of Fantribe Inc.
Reno Calabrigo acting CEO of Tritent International stated, "We have been looking for the right private Company in the proper sector to bring maximum shareholder value to Tritent International for some time. The professional team and multi-million dollar platform of Fantribe™ with past client relationships including Sony, Disney and the Jacksonville Jaguars gives the Company immediate credibility. We expect to be announcing new athlete and celebrity partnerships upon completion of the acquisition."
The terms of the Fantribe acquisition will be released upon executing the Definitive Share Exchange Agreement expected to be completed no later than January 15, 2025. The closing of the transaction between Tritent and Fantribe™ is subject to a number of conditions, including the execution of related transaction documents, and the conditional approval of the OTC Markets Exchange for the listing of Fantribe Shares following completion of tax-free Share Exchange Agreement by the parties.
About Fantribe™
Fantribe™ http://fantribe.com/ is a revolutionary digital platform connecting athletes, celebrities, and influencers directly with their fans. Our mission is to provide a unique, engaging, and monetizable experience for all parties involved. Fantribe enables athletes and celebrities to create and sell exclusive content, such as behind-the-scenes footage, training sessions, and personalized messages. Fans can purchase and access this content through our user-friendly platform, fostering a deeper connection between fans and their idols. Fantribe has worked with partnerships including Disney, Sony and the Jacksonville Jaguars. The Fantribe platform will feature seamless features and social tools for our athletes, celebrities and content creators to interact with fans and build a community with unique tools and access methods.
About Tritent International Corp.
Tritent International Corp. is a publicly traded company and diversified corporation focusing on strategic alliances within the Real Estate, Energy and Logistic sector. Our strategy is aimed towards the acquisition of controlling equity interests in disruptive companies by taking an active role to improve their growth, provide capital and management expertise.
Forward Looking Statements:
The information set forth in this press release includes statements, estimates, projections with respect to our anticipated future performance and other forward-looking statements, which are subject to risks, uncertainties, and assumptions. In some cases, you can identify these statements by forward-looking words such as "may", "might", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential", "future" or "continue", the negative of these terms and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections are based upon various assumptions that we made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of these statements, estimates or projections. Our actual performance may be materially different from the statements, estimates or projections set forth below. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations.
The forward-looking information in this news release includes disclosure about the terms of the Transaction and the proposed structure of the Transaction. Tritent and Fantribe made certain material assumptions, including but not limited to: prevailing market conditions; general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the resulting issuer to execute and achieve its business objectives, to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to: adverse market conditions; the inability of Tritent or Fantribe to complete the Transaction on the terms disclosed in this news release, or at all; the unavailability of exemptions from prospectus requirements for the issuance of Shares; the risks associated with the marketing and sale of Shares; refusal of the proposed directors or officers to act for any reason, including conflicts of interest; reliance on key and qualified personnel; and regulatory and other risks associated with the pharmaceutical industry in general. The foregoing list of material risk factors and assumptions is not exhaustive.
For more information, please contact:
Fantribe Inc.
Michael Friedman, President
[email protected]
For Tritent International Corp.
Reno Calabrigo, Director
Email: [email protected]
Contact Information
Michael Friedman
President
[email protected]
[email protected]
SOURCE: Fan Tribe Inc.
Ch.Kahalev--AMWN